|
|
 Previous Article | Table of Contents | Next Article 
Blood, Vol. 94 No. 8 (October 15), 1999:
pp. 2696-2703
Targeting of a Heterologous Protein to a Regulated Secretion
Pathway in Cultured Endothelial Cells
Yvonne H. Datta,
Hagop Youssoufian,
Peter W. Marks, and
Bruce M. Ewenstein
From the Division of Hematology, Brigham and Women's Hospital,
Boston, MA.
The stimulation of regulated exocytosis in vascular endothelial
cells (EC) by a variety of naturally occurring agonists contributes to
the interrelated processes of inflammation, thrombosis, and fibrinolysis. The Weibel-Palade body (WPB) is a well-described secretory granule in EC that contains both von Willebrand factor (vWF)
and P-selectin, but the mechanisms responsible for the targeting of
these proteins into this organelle remain poorly understood. Through
adenoviral transduction, we have expressed human growth hormone (GH) as
a model of regulated secretory protein sorting in EC.
Immunofluorescence microscopy of EC infected with GH-containing recombinant adenovirus (GHrAd) demonstrated a granular distribution of
GH that colocalized with vWF. In contrast, EC infected with an rAd
expressing the IgG1 heavy chain (IG), a constitutively secreted protein, did not demonstrate colocalization of IG and vWF. In
response to phorbol ester, GH as well as endogenously synthesized vWF
were rapidly released from GHrAd-infected EC. By
immunofluorescence microscopy, granular
colocalization of GH with endogenous tissue-type plasminogen activator
(tPA) was also demonstrated, and most of the tPA colocalized with vWF.
These data indicate that EC are capable of selectively targeting
heterologous proteins, such as GH, to the regulated secretory pathway,
which suggests that EC and neuroendocrine cells share common protein targeting recognition signals or receptors.
 CiteULike  Connotea  Del.icio.us  Digg  Reddit  Technorati What's this?
This article has been cited by other articles:
|
|
|
|
 
A. Reijerkerk, G. Kooij, S. M. A. van der Pol, T. Leyen, B. van het Hof, P.-O. Couraud, D. Vivien, C. D. Dijkstra, and H. E. de Vries
Tissue-Type Plasminogen Activator Is a Regulator of Monocyte Diapedesis through the Brain Endothelial Barrier
J. Immunol.,
September 1, 2008;
181(5):
3567 - 3574.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
J. H. Cleator and D. E. Vaughan
Clinical Implications of the Contrasting Effects of In Vivo Thrombin Receptor Activation (Protease-Activated Receptor Type 1) on the Human Vasculature
J. Am. Coll. Cardiol.,
May 6, 2008;
51(18):
1757 - 1759.
[Full Text]
[PDF]
|
|
|
|
|
|
|
J. H. Cleator, W. Q. Zhu, D. E. Vaughan, and H. E. Hamm
Differential regulation of endothelial exocytosis of P-selectin and von Willebrand factor by protease-activated receptors and cAMP
Blood,
April 1, 2006;
107(7):
2736 - 2744.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
I. Oynebraten, N. Barois, K. Hagelsteen, F.-E. Johansen, O. Bakke, and G. Haraldsen
Characterization of a Novel Chemokine-Containing Storage Granule in Endothelial Cells: Evidence for Preferential Exocytosis Mediated by Protein Kinase A and Diacylglycerol
J. Immunol.,
October 15, 2005;
175(8):
5358 - 5369.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
I. Oynebraten, O. Bakke, P. Brandtzaeg, F.-E. Johansen, and G. Haraldsen
Rapid chemokine secretion from endothelial cells originates from 2 distinct compartments
Blood,
July 15, 2004;
104(2):
314 - 320.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
D. Huber, E. M. Cramer, J. E. Kaufmann, P. Meda, J.-M. Masse, E. K. O. Kruithof, and U. M. Vischer
Tissue-type plasminogen activator (t-PA) is stored in Weibel-Palade bodies in human endothelial cells both in vitro and in vivo
Blood,
May 15, 2002;
99(10):
3637 - 3645.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
M. S. Pepper
Role of the Matrix Metalloproteinase and Plasminogen Activator-Plasmin Systems in Angiogenesis
Arterioscler. Thromb. Vasc. Biol.,
July 1, 2001;
21(7):
1104 - 1117.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
B. P. Schick, J. F. Gradowski, and J. D. S. Antonio
Synthesis, secretion, and subcellular localization of serglycin proteoglycan in human endothelial cells
Blood,
January 15, 2001;
97(2):
449 - 458.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
H. Bounameaux and E. K. O. Kruithof
On the Association of Elevated tPA/PAI-1 Complex and von Willebrand Factor With Recurrent Myocardial Infarction
Arterioscler. Thromb. Vasc. Biol.,
August 1, 2000;
20(8):
1857 - 1859.
[Full Text]
[PDF]
|
|
|
|
|
